Mark Cuban predicts AI-driven contract analysis could collapse pharmacy-benefit managers (PBMs) by exposing opaque pricing gaps, slashing healthcare costs.
RAND research reveals self-insured employers pay 2.5x Medicare rates for hospital services despite lacking pricing control.
The U.S. Department of Health and Human Services (HHS) on October 30 released a new policy that effectively lowers ...
The rule requires pharmacy benefit managers to disclose rebates and discounts, money made from spread pricing and incentives ...
Employers are dropping GLP-1 coverage for weight loss this open enrollment. Medicare pays $245 a month, and its deal ends in ...
On September 23, 2026, Skadden attorneys Julia York and Rachel Turow discussed the continued scrutiny of life sciences companies ...
Blusher Me on MSN
Insulin prices rose more than 10-fold in alleged scheme, and Pennsylvania wants drug giants to pay
Insulin Prices Rose More Than 10-Fold in Alleged Scheme, and Pennsylvania Wants Drug Giants to Pay ...
Trump has publicly slammed pharma and health insurers for their alleged profiteering off the backs of patients. But his administration’s policies have had little impact.
Attorney General Dave Sunday has issued a lawsuit against several pharmaceutical companies over alleged insulin market manipulation.
Mark Cuban’s healthcare strategy targets high drug costs, insurance complexity and transparency, offering a simpler model ...
A STAT investigation found that older women paid up to $30,000 for overseas mitochondrial replacement therapy, despite limited evidence that three-parent IVF improves fertility or addresses ...
Florida Attorney General James Uthmeier has filed a lawsuit against three of the world’s largest insulin manufacturers, three major pharmacy benefit managers and several rebate aggregators, alleging a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results